NOVARTIS BIOVENTURES LTD. SC 13G 4-6-2016 (AEGLEA BIOTHERAPEUTICS, INC)

Company

Spyre Therapeutics, Inc.

Filed

April 14, 2016

Accession Number

0001140361-16-061144

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →